文献速递泌尿生殖与妇科肿瘤放疗

宫颈癌患者在高收治量医院与低收治量医院接受放射治疗的结果

Outcomes for Cervical Cancer Patients Treated With Radiation in High-Volume and Low-Volume Hospitals.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2018-05-24

该研究利用台湾癌症登记数据库,纳入2007至2013年诊断的2582例FIGO IB至IVA期宫颈癌患者,均接受以根治性放疗为主的治疗(联合或不联合化疗)。研究发现,年收治量≤5例的医院患者年龄更大、分期更晚,化疗和近距离放疗使用率更低;年收治量>5例的医院患者总生存更好(P < .001),化疗和近距离放疗使用率较高是主要贡献因素,但医院收治量本身(>5例/年 vs ≤5例/年)对巨大肿瘤或晚期患者也是独立预后因素。

要点

  • 年收治量≤5例的医院患者年龄更大且分期更晚。
  • 化疗和近距离放疗的使用与医院收治量呈正相关。
  • 年收治量>5例的医院患者总生存优于≤5例者(P < .001)。

核心结论

  • 收治量较小医院宫颈癌患者生存较差,既归因于此类医院标准治疗水平较低,也归因于收治量本身较小。
  • 研究结果提示如何改进中低收治量医院的治疗。

研究设计与样本

  • 利用台湾癌症登记数据库提取2007至2013年诊断的2582例FIGO IB至IVA期宫颈癌患者数据,均接受以根治性放疗为主的治疗(联合或不联合化疗)。
  • 分析医院收治量、临床参数、所接受治疗类型与生存之间的关联。

主要发现

  • 年收治量≤5例的医院患者年龄更大、分期更晚。
  • 化疗和近距离放疗的使用与医院收治量呈正相关。
  • 年收治量>5例的医院患者总生存优于年收治量≤5例者(P < .001)。
  • 逐步多变量分析显示,化疗和近距离放疗使用较多是大收治量医院患者生存更好的主要贡献因素。
  • 医院收治量本身(>5例/年 vs ≤5例/年)对巨大肿瘤或晚期患者也是独立预后因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the effects of different hospital patient loads on the standard of care and treatment outcomes of patients with cervical cancer treated primarily with radiation therapy and to identify factors that may contribute to survival differences among hospitals. METHODS AND MATERIALS: We used the Taiwan Cancer Registry database to extract data on a total of 2582 International Federation of Gynecology and Obstetrics stage IB to IVA patients with uterine cervical cancer diagnosed from 2007 to 2013 who underwent primarily curative radiation therapy (with or without chemotherapy). We explored associations among hospital patient loads, clinical parameters, the type of care given, and survival. RESULTS: Patients who received treatment at hospitals with small and medium patient loads (≤5 cases annually) were older and had more advanced-stage disease than other patients. Positive associations were evident between the use of chemotherapy and brachytherapy and hospital patient load. Patients treated at hospitals with large patient loads (>5 cases annually) experienced better overall survival than those treated at hospitals with small or medium patient loads (P < .001). Stepwise addition of variables to multivariable analyses indicated that greater use of chemotherapy and brachytherapy were major contributors to the better survival of patients treated at hospitals with large patient loads. However, larger hospital patient load per se (>5 vs ≤5 cases annually) was also independently prognostic for better survival of patients with bulky tumors or advanced-stage disease. CONCLUSIONS: We found that the inferior survival rate of patients with cervical cancer treated at hospitals with smaller patient loads was attributable not only to a lower standard of care in such hospitals but also to the smaller patient load. Our findings indicate how treatment should be improved in hospitals with small and medium patient loads.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Lin SM, Ku HY, Chang TC, et al. Outcomes for Cervical Cancer Patients Treated With Radiation in High-Volume and Low-Volume Hospitals. Int J Radiat Oncol Biol Phys. 2018. PMID: 30102195. doi:10.1016/j.ijrobp.2018.05.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。